| |
Tuesday, April 4, 2023 | 10am ET / 7am PT Life sciences leaders are reporting that investments in cloud technology are opening new doors for enhanced productivity, improved time-to-insights, and more. Join this one-hour deep dive into the latest solutions and strategies for successfully accelerating innovation while optimizing costs. Register now. .png)
|
|
| By Max Bayer The latest R&D budget rankings looks a lot like the 2021 list, but Sanofi cracked the list this year and shifts in positions occurred, like Merck reaching the podium after jumping Pfizer for third place. |
|
|
|
By Kevin Dunleavy Analysts at Evercore ISI believe a label expansion for Sanofi and Regeneron’s Dupixent in COPD would add $3.5 billion in sales, expanding the drug’s peak sales potential to more than $20 billion. |
By Max Bayer Bayer has elected to move away from early R&D work focused on women's health. The pharmaceutical company behind the birth control brand Yasmin says it will continue to work on clinical-stage assets in the field. |
By Fraiser Kansteiner After a California judge said a plaintiff's expert witnesses can testify in an upcoming trial over cancer risks on heartburn med Zantac, GSK has hit back. The British drugmaker stressed that litigation is still at an “early stage." |
|
Tuesday, April 11, 2023 | 1pm ET / 10am PT Achieving interoperability in healthcare can be a daunting task, but sharing and collaborating with data has the potential to generate better clinical outcomes, enable new care models, and enhance patient experience. Join healthcare industry experts for this important roundtable discussion to learn more. Register now. 
|
|
By Annalee Armstrong Novartis has hopped on Bicycle Therapeutics’ radio-conjugates ride with a $50 million upfront payment and a further $1.7 billion possible down the road. |
By Nick Paul Taylor The FDA is planning to shake up its approach to the accelerated approval of oncology drugs—and wants to know what you think of its proposals. In draft guidance, the agency outlined plans to move away from single-arm studies and instead favor randomized controlled trials that can potentially serve as the basis for both accelerated and full approval. |
By Sharon Klahr Coey Eli Lilly has officially launched its consumer campaign for Type 2 diabetes drug Mounjaro. The first TV spot “'Diabetes Differently’ premiered on February 12 on Fox. |
By Andrea Park For the first time in at least a decade, the head of Johnson & Johnson’s medtech division is among the company’s highest-paid executives. |
By Angus Liu GSK and Merck provided a new opportunity to compare their PD-1 drugs side by side. After a head-to-head win last year, GSK's Jemperli this time appears to have lost its competitive edge against Merck's Keytruda. |
By Fraiser Kansteiner While commercial revenue has yet to materialize in bluebird bio's earnings report, the company is flying high on the U.S. launches of its two new gene therapies Zynteglo and Skysona. |
By Helen Floersh Though the work is only in the proof-of-concept stage, the “mini organs” could help develop patient-specific therapies for treating thymic dysfunction. |
Fierce podcasts Don't miss an episode |
| This week on "The Top Line," we discuss how 2023 is shaping up to be much the same as last year when it comes to financing trends for biotechs. We also cover Emergent's Narcan winning the first over-the-counter approval for an opioid-overdose drug and more of this week's top headlines. |
|
|---|
|
|
|
Tuesday, April 11, 2023 | 12pm ET / 9am PT In this webinar we will guide you along the scientific data journey where you can discover smart ways to get from raw data to insights and how to achieve an automated, interconnected lab with data liquidity across the organization. Register now. 
|
|
Research The current real-world safety reporting process is too burdensome for most HCPs – how can technology help? Sponsored by: Veradigm |
Whitepaper Preparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
Whitepaper Learn how HCP statements influence patient decisions Sponsored by: ZoomRx - HCP-Patient Dialogue Research |
Whitepaper This paper describes the key elements of good US/EU corporate governance for US-based biopharma companies in operating Europe. Sponsored by: Blue Matter, strategic consultants in the life sciences |
Executive Summary Read about the latest survey results from over 200 biopharma executives and the changing approaches to building biologic drug development pipelines. Sponsored by: Twist Bioscience |
Whitepaper Have you had your questions about mRNA/saRNA manufacturing unanswered during a webinar; have no fear, we have you covered here. Sponsored by: Aldevron |
Whitepaper Download Herspiegel Consulting’s Go-To-Market Model, based on 100+ launches, to learn the critical components, and timelines for commercial success. Sponsored by: Herspiegel Consulting |
eBook Catalent’s Carla Vozone discusses the significant trends in the Orally Inhaled & Nasal Drug Delivery (OINDP) segment including large molecules and novel indications. Sponsored By: Catalent |
Research Learn more on Catalent’s step-wise approach for the definition and execution of Process Characterization for the production of a monoclonal antibody for late phase process characterization and development. Sponsored by: Catalent |
Whitepaper Learn how Catalent’s extensive network across APAC can meet a wide range of clinical supply needs for sponsors conducting trials within the region. Sponsored by: Catalent |
Research Learn more on an approach for process characterization for the production of a monoclonal antibody, which will improve the efficiency and effectiveness of the process by targeting the right design and number of experiments. Sponsored by: Catalent |
Whitepaper Explore Catalent’s newest clinical supply facility in Japan, including the comprehensive services & solutions it offers to help support trials both in-country & around the world. Sponsored by: Catalent |
Case Study Learn more on an approach for process characterization for the production of a monoclonal antibody, which will improve the efficiency and effectiveness of the process by targeting the right design and number of experiments. Sponsored by: Catalent |
| May 1-3, 2023 | Jersey City, NJ |
|
|
| |
|
